retatrutide dosing regimen phase 2 trial The Dosage Chart VisualAbstract: Retatrutide reduces body weight

In the presence of nutrients, the IGF1 (Insulin-like Growth Factor-1) signalling pathway gets activated which promotes glycogen, protein, and lipid synthesis in mammals

PlexusDx Precision Peptide Genetic Test can reveal predispositions in GLP1R, GIPR, FTO, and MC4R pathways to support provider conversations

The headline figure that got attention: a 15.9% non-placebo-adjusted weight loss at 32 weeks on 2.4 mg weekly dosing, with no plateau observed at that timepoint

GLP-1 action may potentially sensitize GIP signaling, which is often compromised in individuals with uncontrolled T2DM

MNT also had the opportunity to speak with Douglas R